Home / Prices / robot-assisted gait training

robot-assisted gait training

Rehabilitation estimated about CNY 350-900

Disclaimer: This site is a medical service platform; some page content is AI-assisted. Health-related information does not constitute medical advice. If you have any questions, please consult a healthcare professional. See full disclaimer

Description

A rehabilitation technique using robotic devices to support and guide lower-limb movement during walking practice, commonly used for neurological or orthopedic recovery.

Main Uses

Primary purpose is neurorehabilitation to restore ambulatory function and improve gait biomechanics in individuals with neurological or musculoskeletal impairments. Key clinical applications include: post-stroke gait retraining, spinal cord injury locomotor recovery, cerebral palsy mobility enhancement, traumatic brain injury balance and walking reintegration, and Parkinson’s disease gait variability reduction. Used in inpatient/outpatient rehabilitation centers, specialized neurorehabilitation clinics, and research settings to deliver high-dose, repetitive, task-specific, and quantifiable gait practice with objective motion capture and real-time feedback.

Normal Range

Robot-assisted gait training is not a diagnostic laboratory test with numerical 'values' or reference ranges; it is a therapeutic rehabilitation intervention. Therefore, there is no universally defined 'normal range' in terms of quantitative metrics. Clinical progress is assessed qualitatively and quantitatively via secondary outcome measures (e.g., walking speed ≥0.8 m/s, Berg Balance Scale score ≥45/56, 6-Minute Walk Test distance ≥300–400 m, Fugl-Meyer Assessment lower extremity score ≥25/34), which vary by patient population, baseline function, and device used (e.g., Lokomat®, G-EO®, HAL®). No standardized biomarker or numeric threshold defines 'normal' performance during robot-assisted training.

Low Values - Possible Causes

1. Severe neuromuscular impairment (e.g., chronic spinal cord injury at T4 or higher, advanced Parkinson’s disease with freezing of gait); 2. Significant cognitive deficits limiting task engagement and motor learning; 3. Orthopedic contraindications (e.g., recent joint replacement, unhealed fractures, severe osteoporosis); 4. Cardiovascular instability (e.g., uncontrolled hypertension, NYHA Class III/IV heart failure); 5. Patient intolerance due to pain, spasticity, or anxiety related to robotic interface or weight-bearing.

High Values - Possible Causes

1. High baseline functional capacity enabling rapid adaptation and increased training intensity (e.g., subacute stroke patients with minimal paresis); 2. Optimal neuroplastic responsiveness (e.g., younger age, shorter time since injury, intact corticospinal tract integrity on DTI); 3. High adherence and motivation leading to greater session frequency/duration and progressive overload; 4. Advanced robotic system capabilities (e.g., real-time adaptive control, high-fidelity biofeedback, integrated exoskeletal assistance) facilitating superior kinematic and kinetic output; 5. Concurrent multimodal therapy (e.g., combined with transcranial magnetic stimulation or intensive physical therapy) amplifying neurorehabilitation effects.

robot-assisted gait training neurorehabilitation therapy gait rehabilitation

estimated about CNY 350-900